Clinical Trials Logo

Clinical Trial Summary

Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of Breast Implant Illness. Three patient cohorts will be studied (A) Subjects with breast implant with BII manifestations (B) Subjects with breast implants without BII manifestations (C) Subjects without breast implants who underwent breast surgery procedure. Blood, surgically discarded tissue, implants, and associated capsules will be collected through this protocol.


Clinical Trial Description

Breast implants were first introduced in 1962. It is estimated that 10 million women worldwide, including three million Americans have breast implants. There has been increased identification of patients experiencing a constellation of symptoms related to their implants. For breast implants, these symptoms are often associated with autoimmune and connective tissue disorders (CTD) and have been referred to as Breast Implant Illness (BII). A growing number of patients 30,000 annually are seeking to have their breast implants removed. In view of the implant associated complications, the US Food and Drug Administration (FDA) has placed a black box warning on breast implants. Limited research has resulted in a void in the prognosis of this surgical problem. Bacterial biofilms are becoming a major concern for medical device implants. Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of BII. This research studies oxilidized lipids (oxylipins). These are metabolities formed as a result of host-biofilm interaction. The presence of oxylipins will be studied in peri-prosthetic tissue post-biofilm infection and in systemic circulation. Oxylipins are immunogenic. Hence, the investigators will also study the abundance of immune cells T cells and macrophages (types and subtypes) and associated cytokines. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05736354
Study type Observational
Source Indiana University
Contact Mithun Sinha, PhD.
Phone 3172782713
Email mitsinha@iu.edu
Status Recruiting
Phase
Start date January 3, 2021
Completion date June 30, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05987475 - Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants
Recruiting NCT05345821 - An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface
Recruiting NCT06414785 - Characterization of Capsule Inflammation in Patients Exposed to Silicone Breast Implants
Completed NCT04783818 - Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction
Completed NCT04854525 - Breast Reconstruction in Previously Irradiated Breast
Completed NCT03737500 - Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer N/A
Completed NCT06139588 - Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction
Recruiting NCT03356132 - An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants
Recruiting NCT05017337 - Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular Contracture
Enrolling by invitation NCT05400954 - Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases
Active, not recruiting NCT04968457 - Multicenter Post-marketing Survey of SEBBIN Group Silicone Gel-filled Breast Implants
Recruiting NCT03730922 - Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy N/A
Completed NCT03784859 - Tissue Expansion in Breast Reconstruction Without Drains
Active, not recruiting NCT06332937 - Breast Reconstruction
Recruiting NCT05757778 - Split Chest Breast Neurotization N/A
Recruiting NCT06274736 - Safety and Performance of Motiva® Sizers
Recruiting NCT05899387 - Seroma of the Mammary Gland